Lupin has informed that its Japanese subsidiary Kyowa Pharmaceutical Industry Co announced the listing of NHI Drug Price for Bipresso extended release tablets for the treatment of depressive symptoms associated with bipolar disorder.
The above information is a part of company’s filings submitted to BSE.